Chemoinformaics analysis of Aristolene
Molecular Weight | 204.357 | nRot | 0 |
Heavy Atom Molecular Weight | 180.165 | nRig | 13 |
Exact Molecular Weight | 204.188 | nRing | 3 |
Solubility: LogS | -5.574 | nHRing | 0 |
Solubility: LogP | 4.855 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 41.053 |
nHD | 0 | BPOL | 24.077 |
QED | 0.513 |
Synth | 4.217 |
Natural Product Likeliness | 3.004 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.081 |
Pgp-sub | 0 |
HIA | 0.003 |
CACO-2 | -4.492 |
MDCK | 0.0000126 |
BBB | 0.743 |
PPB | 0.942758 |
VDSS | 2.784 |
FU | 0.0503058 |
CYP1A2-inh | 0.291 |
CYP1A2-sub | 0.594 |
CYP2c19-inh | 0.439 |
CYP2c19-sub | 0.921 |
CYP2c9-inh | 0.393 |
CYP2c9-sub | 0.759 |
CYP2d6-inh | 0.06 |
CYP2d6-sub | 0.75 |
CYP3a4-inh | 0.318 |
CYP3a4-sub | 0.339 |
CL | 14.487 |
T12 | 0.042 |
hERG | 0.002 |
Ames | 0.004 |
ROA | 0.093 |
SkinSen | 0.051 |
Carcinogencity | 0.119 |
EI | 0.364 |
Respiratory | 0.916 |
NR-Aromatase | 0.096 |
Antiviral | Yes |
Prediction | 0.911264 |